Janette Dixon DBA, Director and Chief Executive Officer

Formerly a medical laboratory scientist, Dr. Janette Dixon has extensive commercial experience at executive management and director level in both start-up and corporate organizations in the fields of pharmaceuticals and clinical diagnostics.  She previously founded and sold diagnostics companies based in Singapore and Malaysia and founded a pharmaceutical company in Singapore, managing the development of a drug for the eradication of Helicobacter pylori from the acquisition of intellectual property through to completion of Phase 2a clinical studies.  Dr. Dixon has broad business development and licensing experience across Asia Pacific, North America and Europe.  She previously held the role of Managing Director at Pacific Pharmaceuticals Ltd and led the restructuring of New Zealand’s largest pharmaceutical manufacturing company, outsourcing production of 130 pharmaceutical products into six countries.  Dr. Dixon holds a Master’s Degree in Applied Finance and a Doctorate in Business and Administration wherein her research focused on the strategic management of biotech commercialization. 

Mathew Lo PhD, Drug Development Consultant

Dr. Lo held various positions at AstraZeneca within the Drug Discovery, Clinical Development and International Sales and Marketing from 1989 to 2012, including that of Senior Director and Product Development Team Leader at MedImmune LLC (an AstraZeneca subsidiary).  Dr. Lo completed his PhD at Imperial College, University of London, in 1980. He was a postdoctoral fellow at the Johns Hopkins University School of Medicine from 1981 to 1985, and held an intramural research position at the National Institute on Drug Abuse Addiction Research Center until 1989. He currently consults with biotech and pharmaceutical companies.

Louise Bussieres CPA, CA, Chief Financial Officer

Louise is a Certified Public Accountant with 35 years experience in accounting and finance. She plays several executive roles as well as having other consulting interests as Partner in L2 Consulting Pte. Ltd. and L2 Consulting Inc. Throughout her career, Ms. Bussieres has sat on several boards and has been involved in strategic planning, financing, accounting, mergers and acquisitions, treasury and contract negotiations in the pharmaceutical research and development field and has had notable success in several important positions in publicly traded organisations.